Upcoming event
EAU UROonco: A meeting steered by the EAU Section of Oncological Urology
Back

Tag: EAU22

ESOU Online: EAU22 highlights in prostate cancer

Case presentation – Risk stratification: Using circulating ctDNA to stage renal cancer

Patient engagement is a potential blockbuster treatment that urologists should prescribe for their cancer patients

Debate – NMIBC BCG refractory tumour – What are the systemic options in the pipeline?

EAU22 BCa highlights

Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs. open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer: a randomised clinical trial

Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010

18F-DCPyL PSMA PET/CT and mpMRI prostate: A prospective comparison of ability to diagnose and locate prostate cancer (PEDAL study)

18F-DCPyL PSMA PET/CT and mpMRI prostate: A prospective comparison of ability to diagnose and locate prostate cancer (PEDAL study) – Discussant

Overall survival (OS) by circulating tumor DNA (ctDNA) status in patients with post-operative muscle-invasive urothelial carcinoma (MIUC) treated with atezolizumab (atezo): update from IMvigor010